BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

Insilico Medicine and China Medical System Expand AI Drug Discovery Alliance with RMB 1.2 Billion CNS Collaboration

Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Med...

July 13, 2026 | News

Mindbeam AI Unveils Generative AI Breakthrough for Safer Next-Generation Pain Therapies

Mindbeam AI, the company focused on next-generation AI infrastructure, announced a new research breakthrough showing how generative AI can accelerate...

July 13, 2026 | News

The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.

A control room that thinks it knows what happens next Walk the mezzanine above a modern biologics suite in Singapore, Songdo or Hyderabad and the change i...

July 13, 2026 | Analysis

Insilico Medicine Advances AI-Discovered IPF Drug Rentosertib into Phase III Trial

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-...

July 09, 2026 | News

Sanyou Bio, Baiyunshan Xihe Forge Strategic Alliance to Advance AI-Powered Radiopharmaceutical Innovation

Sanyou Biopharmaceutical Co., Ltd. ("Sanyou Bio") and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. ("Baiyunshan Xihe") jointly announced the o...

July 06, 2026 | News

SK Bioscience to Lead Gates Foundation-Backed AI Platform for Vaccine Clinical Development

SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. SK bioscience, PATH, Slalom...

July 06, 2026 | News

Takeda Partners with Insilico Medicine in Up to $600M AI Drug Discovery Collaboration

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas Insilico Medicine ("Insilico" HKEX:3696),...

July 03, 2026 | News

METiS TechBio Signs US$1.62 Billion Licensing Deal for AI-Designed Cancer Therapy with Boulevard Bio

METiS TechBio (7666.HK), a leading AI-driven drug delivery innovation company, announced it has entered into an exclusive global licensing agreement ...

July 02, 2026 | News

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced that it has joined Anthropic’s life sciences ecosystem and l...

July 02, 2026 | News

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavem...

June 23, 2026 | News

LG AI Research and D&D Pharmatech Join Forces to Accelerate AI-Powered Oral Peptide Drug Discovery

- LG to secure leadership in the AI-bio market with its distinctive technological edge. LG AI Research announced that it has signed a ...

June 19, 2026 | News

Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced it has ach...

June 18, 2026 | News

QingSong Health and Basel Medical Group Forge Strategic Alliance to Advance AI Healthcare in Southeast Asia

QingSong Health Corp (2661.HK) and Basel Medical Group Ltd announced the signing of a Memorandum of Strategic Cooperation. The two parties i...

June 15, 2026 | News

PromptBio Launches Agentic AI Platform to Accelerate Scientific Discovery

The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PromptBio, a Californ...

June 11, 2026 | News

Stay Connected